Healthconn

Healthconn AAQS

The The AAQS of Healthconn (6665.TWO) as of Nov 3, 2026 is 4. In the previous year, The AAQS was 4.00 — a change of 0.00% (lower).

AAQS

4

YoY

0.00%

Last updated:

Healthconn has a current AAQS of 4.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock Healthconn in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

The Healthconn AAQS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

AAQS
Date
AAQS
Jan 1, 2018
4.00 TWD
Jan 1, 2019
4.00 TWD
Jan 1, 2020
4.00 TWD
Jan 1, 2021
4.00 TWD
Jan 1, 2022
4.00 TWD
Jan 1, 2023
4.00 TWD
Jan 1, 2024
4.00 TWD
Jan 1, 2025
4.00 TWD
The Healthconn AAQS history
YEARAAQSYoY
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
4—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Healthconn Stock analysis

What does Healthconn do? Healthconn Corp offers tailored lifestyle optimization solutions across nutrition, exercise, stress management, and sleep. The company provides precisely prevent medical integration services, including precise prevention, disease management, and health promotion. Molecular biology testing programs cover food safety and functional medical testing, while accurate diagnostic testing services encompass molecular and clinical microbiological testing. Healthconn also develops and operates medical health institutions and sells medical equipment. Its primary markets are Taiwan and mainland China, serving clients seeking integrated health and medical solutions. The firm’s revenue streams include precisely prevent medical integration services, molecular biology testing programs, accurate diagnostic testing services, and medical equipment sales. Clients are individuals and organizations focused on preventive healthcare, wellness, and diagnostic accuracy. The company targets the Taiwan and mainland China markets, delivering comprehensive health services through its medical health institutions and testing programs. Healthconn Corp’s business model combines lifestyle optimization with medical services, leveraging molecular testing and diagnostic capabilities. By integrating prevention, disease management, and health promotion, it caters to clients prioritizing proactive health strategies. The medical equipment sales segment complements its service offerings, enhancing accessibility to health solutions in Taiwan and mainland China. Healthconn is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Healthconn stock

The AAQS of Healthconn is 4 in 2025.

On Eulerpool you can find the complete historical development of The AAQS Healthconn since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Healthconn

All Key Metrics — Healthconn